The pipeline includes i) WGS data analysis flow for mouse tumour somatic variant discovery (Fig. 2), ii) RNA-seq data analysis flow for gene expression analysis, and iii) neoantigen analysis flow for neopeptide prediction and MHC antigen presentation evaluation (Fig. 3). The gene discussed is HLA-C; the disease is neoplasm.